Regulation of ERK1 and ERK2 by Glucose and Peptide Hormones in Pancreatic β Cells
Year: 2003
Type: article
Abstract: We showed previously that ERK1/2 were activated by glucose and amino acids in pancreatic beta cells. Here we examine and compare signaling events that are necessary for ERK1/2 activation by glucose and other stimuli in beta cells. We find that agents that interrupt Ca2+ signaling by a variety of mechanisms interfere with glucose- and glucagon-like peptide (GLP-1)-stimulated ERK1/2 activity. In particular, calmodulin antagonists, FK506, and cyclosporin, immunosuppressants that inhibit the calcium-dependent phosphatase calcineurin, suppress ERK1/2 activation by both glucose and GLP-1. Ca2+ signaling from intracellular stores is also essential for ERK1/2 activation, because thapsigargin blocks ERK1/2 activation by glucose or GLP-1. The glucose-sensitive mechanism is distinct from that used by phorbol ester or insulin to stimulate ERK1/2 but shares common features with that used by GLP-1.
Source: Journal of Biological Chemistry
Authors: Don Arnette, Tara Beers Gibson, Michael C. Lawrence, Bridgette January, Shih Khoo, Kathleen McGlynn, Colleen A. Vanderbilt, Melanie H. Cobb
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Award: MAP KINASE IN ISLET FUNCTION
OpenAlex ID: W2050190427
